| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 06/14/2006 | EP1668985A2 Nucleophile substituted ecteinascidins and N-oxide ecteinascidins |
| 06/14/2006 | EP1667635A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 06/14/2006 | CN1787995A Alpha, omega-dicarboximide derivatives as useful uro-selective alpha1alpha adrenoceptor blockers |
| 06/14/2006 | CN1787817A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 06/14/2006 | CN1785979A Preparation method of 3-methyl-2-cinoamoyl-quinoxaline-1,4-dioxide |
| 06/14/2006 | CN1259315C Antagonists of MCP-1 function and methods of use thereof |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/13/2006 | US7060817 Sulfonamide anions as catalysts for NCO oligomerization |
| 06/13/2006 | US7060704 S-aminoalkylsulfonamides, e.g., 3-[4-(3-Chlorophenyl)piperazin-1-yl]propylsulfonyl-2,3-dihydro-1H-indole, used to lower IOP, improvi blood flow to the optic nerve head and the retina, provide neuroprotection, and treat retinal diseases, sleep disorders, depression, and other psychiatric disorders |
| 06/13/2006 | US7060700 Amide derivatives useful as inhibitors of the production of cytokines |
| 06/13/2006 | US7060697 Immunosuppressant compounds and compositions |
| 06/13/2006 | US7060664 Organic compounds |
| 06/13/2006 | CA2260777C Pentafluorobenzenesulfonamides and analogs |
| 06/08/2006 | WO2006060461A1 Substituted piperazines as cb1 antagonists |
| 06/08/2006 | WO2006059149A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/08/2006 | US20060122390 Boronic ester and acid compounds, synthesis and uses |
| 06/08/2006 | US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders |
| 06/08/2006 | US20060122224 Quinoline and quinoxaline compounds |
| 06/08/2006 | US20060122195 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 06/08/2006 | US20060122193 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate |
| 06/08/2006 | US20060122192 Chemical compounds |
| 06/08/2006 | US20060122062 2,2,2-trifluoro-N-[5-methyl-1-(3-trifluoromethylphenyl)-2(1H)-pyridinylidene]-acetamide; herbicides; 1-phenylazinethione and 1-phenylchloroazinium intermediates; 1-phenylpyridones: 5-methyl-1-(3-trifluoromethyl-phenyl)-2(1H)-pyridinone |
| 06/08/2006 | CA2589483A1 Substituted piperazines as cb1 antagonists |
| 06/08/2006 | CA2588864A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/07/2006 | EP1664088A2 Hemiasterlin derivatives and uses thereof |
| 06/07/2006 | EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
| 06/07/2006 | EP1663995A1 Sulfoderivatives of acenaphtho [1,2-b]quinoxaline, lyotropic liquid crystal and anisotropic film on their base |
| 06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 06/07/2006 | EP1663958A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 06/07/2006 | EP1663235A1 Capped pyrazinoylguanidine sodium channel blockers |
| 06/07/2006 | EP1663204A2 C-kit modulators and methods of use |
| 06/07/2006 | EP1425029A4 Peptidomimetics of biologically active metallopeptides |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | CN1781912A Organic metal complex and photoelectronic device, light-emitting element and light-emitting device using thereof |
| 06/07/2006 | CN1781911A Intermediate for producing novel pyrazine derivatives |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/06/2006 | US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists |
| 06/06/2006 | US7056925 Urea kinase inhibitors |
| 06/06/2006 | CA2362632C R-substituted-2- or 3-aminomethyl-4-amino-3,4-dihydro-2h-1,4-benzoxazines as intermediates for producing analgesic agents |
| 06/06/2006 | CA2282585C Pyrazine compounds |
| 06/06/2006 | CA2232913C Process for the preparation of azide derivatives |
| 06/06/2006 | CA2199468C 1,2,3,4-tetrahydroquinoxalinedione derivative |
| 06/01/2006 | WO2006057460A1 Nitrogen-containing fused ring compound and use thereof |
| 06/01/2006 | WO2006056752A1 Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 06/01/2006 | WO2006023617A3 Cyclic amide & ester pyrazinoylguanidine sodium channel blockers |
| 06/01/2006 | WO2005061467A3 Piperazine derivatives as bradykinin antagonists |
| 06/01/2006 | US20060116385 Novel compounds having selective inhibiting effect at gsk3 |
| 06/01/2006 | US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 06/01/2006 | US20060116362 Nobel compounds having selective inhibiting effect at gsk3 |
| 05/31/2006 | EP1661569A1 Compounds effecting glucokinase |
| 05/31/2006 | EP1661568A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661567A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661563A1 Compound effecting Glucokinase |
| 05/31/2006 | EP1660471A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 05/31/2006 | EP1660461A1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases |
| 05/31/2006 | EP1660460A1 Quinoxaline derivatives as neutrophil elastase inhibitors and their use |
| 05/31/2006 | EP1660459A2 Arylsulfonamidobenzylic compounds |
| 05/31/2006 | EP1660443A2 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1660184A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/31/2006 | CN1780820A Quinoxalinone-3- one derivatives as orexin receptor antagonists |
| 05/31/2006 | CN1778800A Chiral piperazine substrated quinolone carboxylic acid derivative, and preparation and use thereof |
| 05/31/2006 | CN1257896C Functional molecule material containing four tertiary amine branches and preparation method |
| 05/30/2006 | US7053104 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 05/30/2006 | US7053090 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/26/2006 | WO2005108358A3 Pyrrolidine derivatives useful as bace inhibitors |
| 05/25/2006 | US20060111571 Tadalafil crystal forms and processes for preparing them |
| 05/25/2006 | US20060111406 Amide linker peroxisome proliferator activated receptor modulators |
| 05/25/2006 | US20060111360 Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1658277A1 Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament |
| 05/24/2006 | DE19629258B4 Verfahren zur Herstellung von Pyrazinverbindungen A process for preparing pyrazine compounds |
| 05/24/2006 | CN1777592A Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives |
| 05/24/2006 | CN1777589A Heteroarylcarbamoylbenzene derivative |
| 05/24/2006 | CN1777577A Antibacterial agents |
| 05/24/2006 | CN1775763A Carboxyl acylamide compound and its preparing method and use |
| 05/24/2006 | CN1775762A Liyustrazine acyl piperazine derivative, and its preparing method and medicinal composition and use |
| 05/24/2006 | CN1775752A Optical pure diamide compound and its use |
| 05/23/2006 | US7049316 Prodrugs of CC-1065 analogs |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/18/2006 | WO2006050964A2 Indinavir derivatives useful in immunoassay |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | US20060106059 Melanocortin receptor ligands |
| 05/18/2006 | US20060106030 N-(4-(4-(2,3 -dichlorophenyl)piperazin-1-yl)but-2-enyl)-1H-indole-2-carboxamide; imaging agents; tomography;diagnosis/medical/; selective, oral bioavailable drugs; nervous system disorders; central nervous system;oral administration; substance abuse ( cocaine/amphetamine); psychosis; Parkinson's |
| 05/18/2006 | CA2585546A1 Indinavir derivatives useful in immunoassay |
| 05/17/2006 | EP1657238A1 Fused pyrimidine derivative and use thereof |
| 05/17/2006 | EP1656361A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 05/17/2006 | EP1656355A2 Piperazine derivatives and methods of use |
| 05/17/2006 | EP1656096A2 Methods of reducing risk of infection from pathogens |
| 05/17/2006 | EP1656022A2 Methods of reducing risk of infection from pathogens |
| 05/17/2006 | EP1551902A4 Anisotropic films based on 1,8-naphthoylene-1 ,2 -benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making |
| 05/17/2006 | EP1377552B1 Metal complexes and therapeutic uses thereof |
| 05/17/2006 | EP1337533B1 Resolution of trans-7-(hydroxy-methyl)octa-hydro-2h-pyrido-1,2a)pyrazine |
| 05/17/2006 | EP1109787B1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 05/17/2006 | CN1772742A Prepn process of high purity 2, 6-dichloro quinoxaline |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/16/2006 | US7045177 Concurrent applying, molecular orientation; dissolving in solvent; applying to substrate; drying |